Litab, Rezavel .

HRN: 10-28-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
CEFUROXIME 500MG (TAB)
08/13/2024
08/19/2024
ORAL
500mg
2 Times A Day
Urinary Tract Infection
Waiting Final Action 
08/14/2024
METRONIDAZOLE 500MG (TAB)
08/14/2024
08/20/2024
PO
1 Tab
TID
Post Partum Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: